Cargando…

Socioeconomic inequality in intermittent preventive treatment using Sulphadoxine pyrimethamine among pregnant women in Nigeria

BACKGROUND: Intermittent preventive treatment using Sulphadoxine pyrimethamine (IPTp-SP) for malaria prevention is recommended for all pregnant women in malaria endemic areas. However, there is limited evidence on the level of socioeconomic inequality in IPTp-SP use among pregnant women in Nigeria....

Descripción completa

Detalles Bibliográficos
Autores principales: Muhammad, Fatima Mahmud, Majdzadeh, Reza, Nedjat, Saharnaz, Sajadi, Haniye Sadat, Parsaeian, Mahboubeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716500/
https://www.ncbi.nlm.nih.gov/pubmed/33276756
http://dx.doi.org/10.1186/s12889-020-09967-w
_version_ 1783619172589109248
author Muhammad, Fatima Mahmud
Majdzadeh, Reza
Nedjat, Saharnaz
Sajadi, Haniye Sadat
Parsaeian, Mahboubeh
author_facet Muhammad, Fatima Mahmud
Majdzadeh, Reza
Nedjat, Saharnaz
Sajadi, Haniye Sadat
Parsaeian, Mahboubeh
author_sort Muhammad, Fatima Mahmud
collection PubMed
description BACKGROUND: Intermittent preventive treatment using Sulphadoxine pyrimethamine (IPTp-SP) for malaria prevention is recommended for all pregnant women in malaria endemic areas. However, there is limited evidence on the level of socioeconomic inequality in IPTp-SP use among pregnant women in Nigeria. Thus, this study aimed to determine the level of socioeconomic inequality in IPTp-SP use among pregnant women in Nigeria and to decompose it into its contributing factors. METHODS: A secondary data analysis of Nigerian demographic and health survey of 2018 was conducted. A sample of 21,621 pregnant women aged between 15 and 49 years and had live birth in the previous 2 years before the survey were included in this analysis. The study participants were recruited based on a stratified two-stage cluster sampling method. Socioeconomic inequality was decomposed into its contributing factors by concentration index. RESULT: Totally 63.6% of pregnant women took at least one dose of IPTp-SP prophylaxis. Among IPTp-SP users, 35.1% took one dose, 38.6% took two doses and 26.2% took three doses and more. Based on both concentration index of 0.180 (p-value = < 0.001, 95% CI: 0.176 to 0.183) and Erreyger’s normalization concentration index 0.280 (p-value = < 0.001, 95% CI: 0.251 to 0.309), the IPTp-SP utilization was pro-rich. The largest contributors to the inequality in IPTp-SP uptake were wealth index (47.81%) and educational status (28.66%). CONCLUSION: Our findings showed that IPTp-SP use was pro-rich in Nigeria. Wealth index and educational status were the factors that significantly contributed to the inequality. The disparities could be reduced through free IPTp service expansion by targeting pregnant women from low socioeconomic status. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-020-09967-w.
format Online
Article
Text
id pubmed-7716500
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77165002020-12-04 Socioeconomic inequality in intermittent preventive treatment using Sulphadoxine pyrimethamine among pregnant women in Nigeria Muhammad, Fatima Mahmud Majdzadeh, Reza Nedjat, Saharnaz Sajadi, Haniye Sadat Parsaeian, Mahboubeh BMC Public Health Research Article BACKGROUND: Intermittent preventive treatment using Sulphadoxine pyrimethamine (IPTp-SP) for malaria prevention is recommended for all pregnant women in malaria endemic areas. However, there is limited evidence on the level of socioeconomic inequality in IPTp-SP use among pregnant women in Nigeria. Thus, this study aimed to determine the level of socioeconomic inequality in IPTp-SP use among pregnant women in Nigeria and to decompose it into its contributing factors. METHODS: A secondary data analysis of Nigerian demographic and health survey of 2018 was conducted. A sample of 21,621 pregnant women aged between 15 and 49 years and had live birth in the previous 2 years before the survey were included in this analysis. The study participants were recruited based on a stratified two-stage cluster sampling method. Socioeconomic inequality was decomposed into its contributing factors by concentration index. RESULT: Totally 63.6% of pregnant women took at least one dose of IPTp-SP prophylaxis. Among IPTp-SP users, 35.1% took one dose, 38.6% took two doses and 26.2% took three doses and more. Based on both concentration index of 0.180 (p-value = < 0.001, 95% CI: 0.176 to 0.183) and Erreyger’s normalization concentration index 0.280 (p-value = < 0.001, 95% CI: 0.251 to 0.309), the IPTp-SP utilization was pro-rich. The largest contributors to the inequality in IPTp-SP uptake were wealth index (47.81%) and educational status (28.66%). CONCLUSION: Our findings showed that IPTp-SP use was pro-rich in Nigeria. Wealth index and educational status were the factors that significantly contributed to the inequality. The disparities could be reduced through free IPTp service expansion by targeting pregnant women from low socioeconomic status. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-020-09967-w. BioMed Central 2020-12-04 /pmc/articles/PMC7716500/ /pubmed/33276756 http://dx.doi.org/10.1186/s12889-020-09967-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Muhammad, Fatima Mahmud
Majdzadeh, Reza
Nedjat, Saharnaz
Sajadi, Haniye Sadat
Parsaeian, Mahboubeh
Socioeconomic inequality in intermittent preventive treatment using Sulphadoxine pyrimethamine among pregnant women in Nigeria
title Socioeconomic inequality in intermittent preventive treatment using Sulphadoxine pyrimethamine among pregnant women in Nigeria
title_full Socioeconomic inequality in intermittent preventive treatment using Sulphadoxine pyrimethamine among pregnant women in Nigeria
title_fullStr Socioeconomic inequality in intermittent preventive treatment using Sulphadoxine pyrimethamine among pregnant women in Nigeria
title_full_unstemmed Socioeconomic inequality in intermittent preventive treatment using Sulphadoxine pyrimethamine among pregnant women in Nigeria
title_short Socioeconomic inequality in intermittent preventive treatment using Sulphadoxine pyrimethamine among pregnant women in Nigeria
title_sort socioeconomic inequality in intermittent preventive treatment using sulphadoxine pyrimethamine among pregnant women in nigeria
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7716500/
https://www.ncbi.nlm.nih.gov/pubmed/33276756
http://dx.doi.org/10.1186/s12889-020-09967-w
work_keys_str_mv AT muhammadfatimamahmud socioeconomicinequalityinintermittentpreventivetreatmentusingsulphadoxinepyrimethamineamongpregnantwomeninnigeria
AT majdzadehreza socioeconomicinequalityinintermittentpreventivetreatmentusingsulphadoxinepyrimethamineamongpregnantwomeninnigeria
AT nedjatsaharnaz socioeconomicinequalityinintermittentpreventivetreatmentusingsulphadoxinepyrimethamineamongpregnantwomeninnigeria
AT sajadihaniyesadat socioeconomicinequalityinintermittentpreventivetreatmentusingsulphadoxinepyrimethamineamongpregnantwomeninnigeria
AT parsaeianmahboubeh socioeconomicinequalityinintermittentpreventivetreatmentusingsulphadoxinepyrimethamineamongpregnantwomeninnigeria